Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival
Modern Pathology, 09/22/09
Schittenhelm J et al. – Annexin-1 upregulation in astrocytomas may contribute to tumor progression and its expression profile is similar to its substrate, EGFR, suggesting a possible regulation thereof.
Methods- Annexin-1 expression was studied in 394 glial neoplasms of all grades of malignancy and 81 normal brain samples by immunohistochemistry using tissue microarrays
- The results were validated using western blot and reverse transcription-PCR (RT-PCR)
- Ependymomas and astrocytomas showed significantly higher mean annexin-1 expression levels in the cytoplasm compared with oligodendrogliomas
- In addition, nuclear staining of annexin-1 in oligodendroglial tumor cells was significantly reduced, which may be used as a diagnostic tool for differentiating between astrocytomas and oligodendrogliomas
- Although annexin-1 expression in ependymomas decreased with the grade of malignancy, diffuse astrocytomas showed a significant increase in cytoplasmic annexin-1-positive tumor cells; however, survival analysis showed that the expression of annexin-1 is not associated with patient survival
- Similar to the EGFR amplification profile, primary glioblastomas had a higher annexin-1 expression level compared with secondary glioblastomas
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy
Cerebrovascular Diseases, 11/10/09
Neonatal seizures and Long QT Syndrome: A cardiocerebral channelopathy
Epilepsia, 11/10/09
Neurological symptoms in patients with biopsy proven celiac disease
Movement Disorders, 11/03/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Cancer Chemotherapy and Pharmacology, 10/29/09
Reirradiation for progressive brain metastases
Journal of Cancer Research and Therapeutics, 10/27/09
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


